$AFIB News

Last published 1y ago

1y agoAFIBAcutus Medical Announces Operational DownsizingGlobeNewswireCARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), today announced a realignment of resources and operational downsizing. Dr. Shaden Marzouk,
3y agoAFIBAcutus Medical to Cancel Third Quarter 2023 Conference CallGlobeNewswireCARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), today announced that, following the Company's announcement of its strategic realignment of resources
3y agoAFIBAcutus Medical Reports Third Quarter 2023 Financial ResultsGlobeNewswireCARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter revenue of
3y agoAFIBAcutus Medical Announces Strategic Realignment of Resources and Corporate RestructuringGlobeNewswireCARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), today announced a realignment of resources and corporate restructuring. Scott Huennekens, Chairman of
3y agoAFIBAcutus Medical to Announce Third Quarter 2023 Financial ResultsGlobeNewswireCARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical, Inc. (AFIB) Q2 2023 Earnings Call TranscriptEarnings Call Transcripts
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical to Present at the 43rd Annual Canaccord Growth ConferenceGlobeNewswireCARLSBAD, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced
3y agoAFIBAcutus Medical to Announce Second Quarter 2023 Financial ResultsGlobeNewswireCARLSBAD, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., July 03, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023GlobeNewswireCARLSBAD, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, is pleased
3y agoAFIBAcutus Medical Reports First Quarter 2023 Financial ResultsGlobeNewswireCARLSBAD, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical to Announce First Quarter 2023 Financial ResultsGlobeNewswireCARLSBAD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced
3y agoAFIBAcutus Medical Announces Preliminary Unaudited First Quarter 2023 ResultsGlobeNewswireCARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBRECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation TherapyGlobeNewswireCARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewswireCARLSBAD, Calif., March 16, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical to Announce Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewswireCARLSBAD, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAAON ABM ACA AFIB+25Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap ConferencesACCESS NewswireNEW YORK, NY / ACCESSWIRE / February 14, 2023 / Sidoti & Company, LLC announces that its two spring conferences are now open for registration. The March Virtual Small-Cap Conference will take place on Wednesday and
3y agoAFIBLate-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation CatheterGlobeNewswireCARLSBAD, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial OfficerGlobeNewswireCARLSBAD, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF SymposiumGlobeNewswireCARLSBAD, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today
3y agoAFIBAcutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to MedtronicGlobeNewswireCARLSBAD, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5GlobeNewswireCARLSBAD, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today
3y agoAFIBAcutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping CatheterGlobeNewswireCARLSBAD, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or "the Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
3y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
4y agoAFIBAcutus Medical Reports Third Quarter 2022 Financial ResultsGlobeNewswireCARLSBAD, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
4y agoAFIBAcutus Medical Achieves OEM Qualification Milestone in Sale of Left-Heart Access Portfolio to MedtronicGlobeNewswireCARLSBAD, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
4y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
4y agoAFIBAcutus Medical to Announce Third Quarter 2022 Financial ResultsGlobeNewswireCARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced
4y agoAFIBAcutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & SystemGlobeNewswireCARLSBAD, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
4y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on Oc
4y agoAFIB AVGR HYPR NUVA+1BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory CouncilGlobeNewswireSAN JOSE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President
4y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted an equity award on
4y agoAFIBAcutus Medical Reports Second Quarter 2022 Financial ResultsGlobeNewswireCARLSBAD, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for
4y agoAFIBAcutus Medical, Inc. (AFIB) Q2 2022 Earnings Call TranscriptEarnings Call TranscriptsAFIB earnings call for the period ending June 30, 2022.
4y agoAFIBAcutus Medical to Announce Second Quarter 2022 Financial ResultsGlobeNewswireCARLSBAD, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its sec
4y agoAFIBAcutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in JapanGlobeNewswireCARLSBAD, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced approval of its AcQMap High
4y agoAFIBAcutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue ResultsGlobeNewswireCARLSBAD, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that David
4y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., July 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on Ju
4y agoAFIBAcutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth PrioritiesGlobeNewswireCARLSBAD, Calif., July 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the complet
4y agoAFIBAcutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Delivery SystemGlobeNewswireCARLSBAD, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the commercial launch of an
4y agoAFIBAcutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCARLSBAD, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on Ju